Abstract
Background: Tick-borne encephalitis (TBE) is a severe but vaccine-preventable viral infection of the central nervous system. Reported incidence does not fully capture TBE risk among unvaccinated individuals or the burden of TBE virus (TBEV) infections. To address this, we estimated TBE incidence among unvaccinated adults and TBEV infections compared with reported cases. Methods: We combined TBE surveillance data, vaccination coverage and vaccine effectiveness (VE) estimates, and published and newly generated serological data. The primary surveillance period was 2017-2021. Incidence among unvaccinated adults (IUV) was estimated by adjusting reported incidence for vaccination coverage and VE. Infection hazard (IH) was estimated from seroprevalence and seroreversion using a reversible catalytic model, and clinical fraction was calculated as IUV divided by IH. Findings: Between 2017 and 2021, an average of 268 TBE cases per year were reported among adults aged 18-79 years in Switzerland. After adjustment for vaccination, IUV was 6.56 per 100,000, exceeding the WHO “highly endemic” threshold. In Zurich, 9.9% (15/151) of adults without documented TBEV, JEV, or YFV vaccination were seropositive or borderline for TBEV-specific IgG. Across seven included cantons, pooled IH was 1.60% per year, corresponding to an estimated 10-year infection risk of approximately 15%; pooled clinical fraction was 0.50%, corresponding to approximately 200 infections per reported case. Interpretation: Reported TBE incidence substantially underestimates both disease risk among unvaccinated adults as well as total TBEV infection burden in Switzerland. Accounting for vaccination coverage, VE, and antibody seroreversion provides a more complete basis for interpreting TBE risk.